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AbstrACt
Objectives Cardiovascular disease (CVD) is of increasing 
concern among breast cancer survivors. However, 
evidence on ethnic differences in CVD among women with 
breast cancer is sparse. We assessed ethnic differences 
in cardiovascular morbidity and mortality among patients 
with breast cancer in the Netherlands.
Methods A nationwide register-based cohort study 
comprising all women with a first admission for breast 
cancer (n=127 714) between 1996 and 2010 in the 
Netherlands was conducted. Differences in CVD admission, 
CVD mortality and overall CVD event, which comprised 
a CVD admission and/or CVD mortality, between the 
largest ethnic minority groups (Surinamese, Moroccan, 
Turkish, Antillean and Indonesian) and the Dutch general 
population (henceforth, Dutch) were investigated using Cox 
proportional hazard models.
results The incidence of cardiovascular outcomes 
varied by the ethnic group. The incidence of an overall 
cardiovascular event was significantly higher for women 
with breast cancer from Suriname (HR 1.46; 95% CI 
1.29 to 1.64) and Turkey (HR 1.25; 95% CI 1.03 to 1.51), 
compared with Dutch women with breast cancer. In 
contrast, Indonesian women with breast cancer had a 
significantly lower risk (HR 0.88; 95% CI 0.81 to 0.96) of 
a cardiovascular event compared with Dutch women with 
breast cancer. The risk of a cardiovascular event did not 
differ between Moroccan and Dutch women with breast 
cancer, whereas for Antillean women the risk was not 
significantly higher.
Conclusions Our findings suggest that Surinamese and 
Turkish women with breast cancer are disadvantaged 
in terms of cardiovascular outcomes compared with 
Dutch women with breast cancer. More work is needed 
to unravel the potential factors contributing to these 
differences.
IntrOduCtIOn 
Due to earlier diagnosis and more effective 
treatment, the survival rate among patients 
with breast cancer has now improved, 
resulting in a growing population of breast 
cancer survivors. In the Netherlands, the 
5-year age-standardised survival rate has 
increased from 80% in 1995–1999 to 85% in 
2005–2009.1 With breast cancer becoming 
a curable disease, comorbidities and death 
from other conditions among breast cancer 
survivors are of increasing concern.
One of the most important comorbidities 
to consider in women with breast cancer is 
cardiovascular disease (CVD), and with the 
growing number of breast cancer survivors, 
a better understanding of the risk of CVD in 
this group is crucial. Studies show that women 
surviving breast cancer have an increased risk 
of CVD morbidity and CVD-specific mortality 
compared with women without breast 
cancer.2 3 Moreover, among breast cancer 
survivors, CVD-related mortality is becoming 
more common than breast cancer-specific 
mortality.4 5 This is attributable to improve-
ments in breast cancer survival due to early 
detection by screening programmes and 
improved treatments.6 7 Additionally, cardio-
toxic effects of breast cancer therapy play a 
role.8 9 Further, survivors are typically older 
than the general population and may be 
more likely to develop CVD because of risk 
factors common to both cancer and CVD.10
Evidence suggests ethnic inequalities in the 
prognosis of breast cancer with a higher risk of 
strengths and limitations of this study
 ► The study builds on data from nationwide registries 
which resulted in a large sample size.
 ► The validity of the linkage of the included registries 
has proved to be high.
 ► Although the study is based on a nationwide cohort 
of patients with breast cancer, absolute numbers are 
somewhat small when divided into different ethnic 
groups.
 ► Data on cardiovascular disease risk factors, such 
as smoking, alcohol and obesity, were not available 
since the study builds on registry data.
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breast cancer-specific and overall mortality among some 
ethnic minority groups.11 12 However, although ethnic 
variation in cardiovascular outcomes in the general popu-
lation exists,13 14 the evidence among patients with breast 
cancer is limited. Data from the USA show that African 
American women with breast cancer had an increased 
risk of dying from CVD compared with white American 
patients with breast cancer.4 However, ethnic composi-
tions and the national context vary across countries and, 
to our knowledge, no European study has examined the 
risk of CVD-related outcomes in different ethnic groups 
among patients with breast cancer. Hence, the aim of this 
study was to explore differences in overall CVD event, 
CVD admission and CVD mortality following a diagnosis 
of breast cancer between the largest ethnic minority 
groups in the Netherlands compared with ethnic Dutch.
MethOds
study sample
This register-based cohort study builds on data from 
different Dutch nationwide registers. The registers and 
linkage procedures used in this cohort study have previ-
ously been described in detail.15 In brief, we linked data 
between the national Dutch hospital discharge register, 
the population register and the cause of death register 
using a record identification number. This number is 
assigned to each resident in the Netherlands with a 
unique combination of birth date, sex and postal code 
(84% of the Dutch population). The Dutch national 
hospital discharge register and cause of death register 
were linked to identify all women with a first admission 
for breast cancer between 1996 and 2010, using the 
International Classification of Diseases (ICD) 9th revi-
sion and ICD 10th revision. Both patients with invasive 
(ICD-9: 174 and ICD-10: C50) and in situ breast cancer 
(ICD-9: 233 and ICD-10: D05) were identified and men 
were excluded. Data from the population register and the 
cause of death register were available until 2012 and data 
from the Dutch hospital discharge register were available 
until 2010. Individuals were followed from the date of 
their first breast cancer admission until (1) CVD admis-
sion, (2) CVD death, (3) death due to other causes, (4) 
first emigration or (5) study end (31 December 2012), 
whichever came first. Linkage of data from the different 
registers was performed in agreement with the privacy 
legislation in the Netherlands. All linkages and analysis 
were performed in a secured environment of Statistics 
Netherlands. The dataset was made available and anal-
ysed in an anonymous form in a secured environment 
of Statistics Netherlands. Prior to publication, Statistics 
Netherlands made sure that none of the analysis results 
showed potential reducibility to the individual level.
ethnic group
Ethnic groups were constructed based on the country 
of birth of the resident and her parents, according to 
the definition of Statistics Netherlands.16 A woman was 
considered a migrant if she was born abroad or at least 
one of the parents was born abroad. Women with both 
parents born in the Netherlands were indicated as being 
Dutch. The major migrant groups residing in the Nether-
lands were included which are those born in Turkey, Suri-
name, Morocco, Indonesia and the Netherlands Antilles.
Outcomes
CVD admission after a diagnosis of breast cancer was 
defined as all admissions with either the primary or 
secondary cause of admission coded as ICD-9: 017.2, 093, 
228, 289.1–289.3, 390–459, 5 57 745–747, 780.2, 782.3, 
7825, 7826, 785, 786.50–786.59, 789.2, 794.30–794.39. 
Cardiovascular mortality was defined as dying from a 
cardiovascular cause after a diagnosis of breast cancer.
Overall cardiovascular event combined the two 
outcomes and comprised a hospital admission for CVD 
and/or a death from a cardiovascular cause.
data analyses
We first presented baseline characteristics as absolute 
numbers and percentages according to the ethnic group. 
Continuous variables were summarised as mean and SD 
or as median and IQR where appropriate. Subsequently, 
we calculated HRs and corresponding 95% CIs using Cox 
proportional hazard regression analyses to assess ethnic 
differences in overall cardiovascular events, and sepa-
rately for hospital admission for CVD and cardiovascular 
mortality between the ethnic minority groups and the 
Dutch (reference group) with adjustment for age as a 
continuous variable, year of admission and type of breast 
cancer. Cox proportional hazard assumptions were tested 
by plotting the log minus log functions for the continuous 
variable age. The assumptions were met in all analyses. All 
analyses were performed using SPSS V.22.0.
Patient and public involvement
No patient or public were involved in this study.
results
Table 1 presents the characteristics of the study popula-
tion by the ethnic group. In total, 127 714 women with a 
first admission for breast cancer between 01 January 1996 
and 31 December 2010 were included in the study, of 
which 5% belonged to an ethnic minority group (table 1). 
Women with more adverse outcomes were in general 
followed for a shorter period. Among migrants, the Antil-
leans presented the smallest group and the Indonesians 
the largest group. In general, the ethnic minority groups 
were younger than the Dutch population when diag-
nosed. During follow-up, 19% of the Dutch population 
experienced a hospital admission due to CVD, whereas 
among the ethnic minorities, the proportion of CVD 
admission ranged from 9% for Moroccans to 19% for 
Surinamese women. A total of 31 203 women with breast 
cancer died during follow-up, of which around 25% were 
due to a cardiovascular cause.
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Table 2 shows the incidence of a CVD event, which 
comprises a hospital admission for CVD and/or dying 
from a cardiovascular cause, among patients with breast 
cancer by the ethnic group. Compared with Dutch women 
with breast cancer, both Surinamese (HR 1.46; 95% CI 
1.29 to 1.64) and Turkish (HR 1.25; 95% CI 1.03 to 1.51) 
women with breast cancer had a higher incidence of 
CVD event after adjustment for breast cancer diagnosis, 
period of breast cancer diagnosis and age. In contrast, 
Indonesian women with breast cancer had a significantly 
lower risk (HR 0.88; 95% CI 0.81 to 0.96) of cardiovas-
cular event compared with Dutch women. Although not 
significant, the Antillean women had a higher incidence 
of CVD event compared with Dutch women. For Moroc-
cans, there were no differences from Dutch women.
Subsequently, we assessed cardiovascular admission 
and cardiovascular mortality separately. Table 3 shows 
the unadjusted and adjusted HRs for a cardiovascular 
admission. Only women from Suriname had a signifi-
cantly higher risk (HR 1.45; 95% CI 1.28 to 1.64) of 
cardiovascular admission compared with Dutch women 
Table 1 Demographic and disease characteristics of women admitted for breast cancer between 1996 and 2010 in the 
Netherlands according to the ethnic group
Dutch Antilleans Indonesians Moroccans Surinamese Turkish
N (%) N (%) N (%) N (%) N (%) N (%)
No of patients 120 809 (100) 454 (100) 3457 (100) 919 (100) 1351 (100) 724 (100)
Mean age at diagnosis (year), SD 60.4 (13.3) 52.8 (11.8) 57.0 (13.1) 47.0 (10.7) 52.8 (12.7) 49.5 (11.4)
Attained age (year) end of follow-up
  ≤44 5029 (4.2) 53 (11.7) 206 (6.0) 230 (25.0) 172 (12.7) 125 (17.3)
  45–59 31 731 (26.3) 197 (43.4) 1262 (36.5) 476 (51.8) 582 (43.1) 336 (46.4)
  60–74 46 671 (38.6) 169 (37.2) 1199 (34.7) 185 (20.1) 421 (31.2) 225 (31.1)
  ≥75 37 378 (30.9) 35 (7.7) 790 (22.9) 28 (3.0) 176 (13.0) 38 (5.2)
Follow-up time (year), median (IQR) 4.5 (6.5) 3.6 (5.8) 4.6 (5.5) 3.6 (6.0) 3.8 (6.0) 4.0 (6.0)
Breast cancer diagnosis
  In situ 9774 (8.1) 45 (9.9) 336 (9.7) 91 (9.9) 131 (9.7) 62 (8.6)
  Invasive 111 035 (91.9) 409 (90.1) 3121 (90.3) 828 (90.1) 1220 (90.3) 662 (91.4)
Period of breast cancer diagnosis (year)
  1996–1999 28 869 (23.9) 66 (14.5) 743 (21.5) 115 (12.5) 230 (17.0) 104 (14.4)
  2000–2003 32 196 (26.7) 121 (26.7) 912 (26.4) 201 (21.9) 326 (24.1) 187 (25.8)
  2004–2007 33 385 (27.6) 139 (30.6) 990 (28.6) 289 (31.4) 420 (31.1) 222 (30.7)
  2008–2010 26 359 (21.8) 128 (28.2) 812 (23.5) 314 (34.2) 375 (27.8) 211 (29.1)
Marital status
  Single/widowed/divorced 53 860 (44.6) 268 (59.0) 1701 (49.2) 301 (32.8) 820 (60.7) 277 (38.3)
  Living with partner/married 66 949 (55.4) 186 (41.0) 1756 (50.8) 618 (67.2) 531 (39.3) 447 (61.7)
Hospital admissions
CVD 23 431 (19.4) 68 (15.0) 515 (14.9) 85 (9.2) 259 (19.2) 101 (14.0)
  Heart failure 3426 (2.8) 11 (2.4) 66 (1.9) 13 (1.4) 30 (2.2) 16 (2.2)
  Myocardial infarction 1482 (1.2)  <10* 25 (0.7)  <10*  <10*  <10*
  Cerebrovascular disease 3529 (2.9)  <10* 82 (2.4)  <10* 34 (2.5)  <10*
Death during follow-up
  Total deaths 29 966 (24.8) 101 (22.2) 665 (19.2) 124 (13.5) 251 (18.6) 96 (13.3)
  Breast cancer cause 12 279 (10.2) 64 (14.1) 301 (8.7) 82 (8.9) 136 (10.1) 51 (7.0)
  Cardiovascular cause 7438 (6.2)  <10* 158 (4.6) 11 (1.2) 50 (3.7) 21 (2.9)
  Other causes 10 249 (8.5) <10* 206 (6.0) 31 (3.4) 65 (4.8) 24 (3.3)
*Not given in line with the Dutch data protection guideline as the number of cases was less than 10.
CVD, cardiovascular disease.
Table 2 Unadjusted and adjusted HRs (95% CI) for a 
cardiovascular event by the ethnic group
Unadjusted
HR (95% CI)
Adjusted
HR (95% CI)
Ethnic group
  Dutch 1.00 (ref.) 1.00 (ref.)
  Surinamese 1.03 (0.92 to 1.16) 1.46 (1.29 to 1.64)
  Moroccans 0.51 (0.42 to 0.63) 1.01 (0.83 to 1.24)
  Turkish 0.71 (0.59 to 0.86) 1.25 (1.03 to 1.51)
  Antilleans 0.83 (0.66 to 1.04) 1.24 (0.98 to 1.56)
  Indonesians 0.76 (0.70 to 0.82) 0.88 (0.81 to 0.96)
Adjusted for age, year of admission and type of breast cancer.
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with breast cancer, whereas women from Indonesia had a 
significantly lower risk of a cardiovascular admission (HR 
0.85; 95% CI 0.78 to 0.93). The unadjusted and adjusted 
HRs for cardiovascular mortality for the different ethnic 
groups are shown in table 4. The adjusted HRs for cardio-
vascular mortality were significantly higher for women 
from Suriname (HR 1.49; 95% CI 1.13 to 1.97) and Turkey 
(HR 1.96; 95% CI 1.27 to 3.01), compared with Dutch 
women, whereas there were no significantly differences 
between women from Indonesia and Dutch women. For 
Moroccan and Antillean women, the numbers of deaths 
due to CVD were too small to perform analyses. In order 
to determine the impact of breast cancer treatment on 
the observed differences in CVD outcomes, a sensitivity 
analysis was performed excluding all women with in situ 
breast cancer. This did not change the results significantly, 
suggesting that cancer status and treatment of cancer is 
not strongly related to CVD outcomes in our study.
dIsCussIOn
Key findings
In this population-based cohort study of women with 
breast cancer in the Netherlands, the risk of cardiovas-
cular outcomes varied by the ethnic group. Women from 
Suriname and Turkey had a higher risk of a CVD event 
compared with Dutch women with breast cancer. When 
separating cardiovascular admission and cardiovascular 
mortality, Surinamese and Turkish women had a higher 
risk of both cardiovascular admission and cardiovas-
cular mortality compared with Dutch women, though 
in Turkish women the results for CVD admission was 
not significant. In contrast, women from Indonesia with 
breast cancer had a lower risk of cardiovascular event 
and cardiovascular admission, but similar risk of cardio-
vascular mortality compared with ethnic Dutch women 
with breast cancer. For Moroccan women, the risk of a 
cardiovascular event did not differ from Dutch women 
with breast cancer, whereas for Antillean women the risk 
was not significantly higher.
discussion of key findings
Evidence shows that ethnic minority and migrant groups 
in general have a lower risk of breast cancer compared 
with the majority population.17 18 However, the results 
of this study indicate that among patients with breast 
cancer, some ethnic minority groups are disadvan-
taged in terms of cardiovascular outcomes compared 
with Dutch women. The results of this study are in line 
with the sparse evidence on ethnic differences in CVD 
mortality among patients with breast cancer in the USA 
which also found some ethnic minority groups to be 
disadvantaged in terms of cardiovascular mortality.4 19 
For example, African America women with ductal carci-
noma in situ of the breast were found to have a higher 
risk of CVD death compared with white American women 
diagnosed with ductal carcinoma in situ of the breast.4 
However, even though CVDs have been shown to vary 
by the ethnic group,13 20 data among patients with breast 
cancer in Europe have been lacking. Previous European 
studies on ethnic disparities in breast cancer prognosis 
have mostly focused on mortality after breast cancer diag-
nosis, and found that some ethnic minority groups have 
higher overall and breast cancer-specific mortality.11 12 21 
Our results thereby add a great value to the existing liter-
ature by showing that women with breast cancer from 
Suriname and Turkey are disadvantaged in terms of 
cardiovascular outcomes compared with Dutch women 
with breast cancer. The higher incidence of CVD event 
among Surinamese women with breast cancer reflects the 
pattern of CVD among Surinamese women in the general 
Dutch population. Previous studies of the general popula-
tion in the Netherlands showed that Surinamese women 
have a higher risk of both acute myocardial infarction 
(AMI) and stroke compared with Dutch women,22 23 as 
well as a higher 5-year CVD mortality after initial admis-
sion for CVD.24 Turkish women with breast cancer were 
in the present study found to have a higher incidence 
of CVD event, compared with Dutch women with breast 
cancer. However, this only partly reflects on the pattern 
among Turkish women in the general population in the 
Netherlands. Previous studies of the general population 
in the Netherlands did not find differences in the inci-
dence of stroke or AMI among Turkish women compared 
with the Dutch majority women.22 23 However, when strat-
ifying on age, a higher incidence of AMI were observed 
Table 3 Unadjusted and adjusted HRs (95% CIs) for a 
cardiovascular admission by the ethnic group
Unadjusted
HR (95% CI)
Adjusted
HR (95% CI)
Ethnic group
  Dutch 1.00 (ref.) 1.00 (ref.)
  Surinamese 1.09 (0.96 to 1.23) 1.45 (1.28 to 1.64)
  Moroccans 0.53 (0.43 to 0.66) 0.92 (0.75 to 1.14)
  Turkish 0.76 (0.63 to 0.93) 1.21 (0.99 to 1.47)
  Antilleans 0.89 (0.70 to 1.13) 1.24 (0.98 to 1.57)
  Indonesians 0.75 (0.69 to 0.82) 0.85 (0.78 to 0.93)
Adjusted for age, year of admission and type of breast cancer.
Table 4 Unadjusted and adjusted HRs (95% CIs) for 
cardiovascular mortality by the ethnic group
Unadjusted
HR (95% CI)
Adjusted
HR (95% CI)
Ethnic group 
  Dutch 1.00 (ref.) 1.00 (ref.)
  Surinamese 0.70 (0.53 to 0.93) 1.49 (1.13 to 1.97)
  Turkish 0.55 (0.36 to 0.84) 1.96 (1.27 to 3.01)
  Indonesians 0.76 (0.65 to 0.89) 0.99 (0.84 to 1.16)
Adjusted for age, year of admission and type of breast cancer.
The number of cardiovascular mortality for the Antilleans and 
Moroccan women was too low.
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in Turkish women aged 50–70 years compared with the 
Dutch majority women.22
The relatively low risk of CVD outcomes among 
Indonesian women with breast cancer is in contrast to 
previous studies of the general Dutch population that 
found no differences in incidence of AMI and a slightly 
higher risk of stroke among Indonesians compared with 
Dutch women.22 23 The reasons for the better CVD prog-
nosis among Indonesian patients with breast cancer are 
unclear. However, Indonesians are well integrated into 
the Dutch society with respect to language and culture 
and have similar income levels and are employed at equal 
rates as the Dutch general population.25 This possibly 
results in better access to healthcare services than other 
minority groups and may underlie the better cardiovas-
cular health outcomes among Indonesian women with 
breast cancer.
Possible explanations for the higher risk of cardiovas-
cular events among Surinamese and Turkish patients with 
breast cancer may include disparities in access to health-
care services and a high-risk factor burden among these 
ethnic minorities in the Netherlands. Regular health 
visits are important for early diagnosis of risk factors that 
can lead to CVD progression and it is possible that differ-
ences in health service utilisation may contribute to the 
observed ethnic differences in CVD risk among patients 
with breast cancer. Evidence on healthcare utilisation 
among patients with breast cancer is scarce, but previous 
evidence of the general population in the Netherlands 
suggests that some ethnic minority populations use more 
general practitioner care than Dutch people do, but 
that they are less likely to use specialised care.26 More-
over, ethnic differences in use of cardiac rehabilitation 
and lower adherence to medication therapy have been 
shown.27–30 A Danish study found that immigrants from 
Pakistan and Turkey did not receive adequate medical 
treatment with beta-blockers after a first AMI compared 
with Danish-born residents.28 In addition, in the Neth-
erlands, Surinamese people have been found to have 
poor blood pressure control compared with their Dutch 
counterparts.30
The relatively high incidence of CVD admission and 
mortality among Turkish, Surinamese and Antillean 
breast cancer women may be explained by the high 
prevalence of cardiovascular risk factors in these popu-
lations. The current study lacked information on CVD 
risk factors and we were therefore not able to address 
the possible contribution of these to the observed ethnic 
differences. However, previous studies of Surinamese 
and Turkish populations in the Netherlands showed that 
hypertension, diabetes mellitus and obesity are more 
common among these populations compared with the 
Dutch general population.30–33 As an example, a previous 
Dutch study showed that the prevalence of hypertension, 
the leading risk factor for CVD worldwide, was higher 
in both Turkish and Surinamese people than in Dutch 
people.30 A previous study found that Antillean women 
have higher risk of certain CVD risk factors then Dutch 
women.34 Further, since Antilleans resemble other ethnic 
groups who have been found to have higher risk of some 
CVD risk factors, such as Surinamese women with African 
background, this might be the case for Antillean women 
as well and suggests the need for further studies among 
this population in the Netherlands. In addition, a study 
from the USA found that African American patients with 
breast cancer have higher prevalence of certain CVD risk 
factors, such as hypertension, diabetes and obesity, prior 
to initiating aromatase inhibitory therapy, compared with 
white American patients with breast cancer of the same 
age.35 Although the ethnic groups are not directly compa-
rable, this may also be the case for some of the ethnic 
groups in the current study, such as the African Suri-
namese and Antillean women. Evidence suggests that the 
presence of CVD risk factors among patients with breast 
cancer at diagnosis is a strong predictive factor for the 
development of cardiovascular damage associated with 
breast cancer therapy.36 The higher risk factor burden in 
some ethnic minority groups may therefore contribute to 
the higher incidence of CVD in these groups.
Additionally, since the risk of CVD has been shown to 
vary according to breast cancer therapy,9 37 the observed 
differences may be explained by variation in the treatment 
received by different ethnic groups. In the current study, 
data on treatment were not available. However, studies 
from the USA and UK have reported that ethnic minority 
women were more likely to receive chemotherapy, which 
was largely explained by more advanced stage and higher 
grade tumours.38 39
Our findings have important clinical and public 
health implications because identifying patients with 
breast cancer who are most vulnerable to cardiovascular 
outcomes is important in order to guide strategies among 
patients with breast cancer. The findings suggest the need 
to increase attention for these women in the cardiovas-
cular risk factor management guidelines in the Nether-
lands and awareness of the observed ethnic differences 
in the risk of cardiovascular outcomes among patients 
with breast cancer should be raised among clinicians 
and incorporated into oncology practices. The observed 
differences suggest the need for further studies to iden-
tify factors explaining these differences. More specific, 
studies addressing the potential contribution of both 
CVD risk factors and type of treatment to the observed 
ethnic differences found in this study are needed. This 
will help to tailor appropriate public health and clinical 
interventions to improve outcomes among patients with 
breast cancers most at risk of adverse CVD outcomes.
strength and limitations
The strength of the current study is the validity of the regis-
ters, the linkage methods and the lack of selection of the 
cohorts. A high validity of both the Dutch National Hospital 
Discharge Register and the Dutch Population Register has 
been demonstrated. In a random sample of the Hospital 
Discharge Register, 99% of the personal, admission and 
discharge data and 84% of the principal diagnoses (validated 
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through medical record review by medical specialists) were 
correctly registered.40 In addition, over 97% of the uniquely 
linked hospital admissions resulting from linkage of the 
Hospital Discharge Register with the Population Register 
were shown to be correctly linked.41
Nonetheless, some limitations must be considered. 
First, although the study is based on a nationwide 
cohort of patients with breast cancer, absolute numbers 
are somewhat small when divided into different ethnic 
groups. Consequently, the numbers were too small to 
investigate different kinds of CVD, which could have 
afforded a more nuanced picture. Second, inherent to 
many national-level databases, we lack detailed data on 
CVD risk factors, such as smoking, alcohol, cholesterol 
and obesity, and therefore, we were unable to do addi-
tional analyses to assess the contribution of these to the 
observed ethnic differences. However, we were able to 
shed light on the potential contributing risk factors to the 
observed differences due to previous studies on ethnic 
differences in risk factors in the Netherlands.30–33 Addi-
tionally, the study lack data on treatment of breast cancer. 
Since, CVD risk has been shown to vary according to type 
of treatment,9 37 adjustment for treatment would have 
been preferable in order to assess the potential impact 
of differences in treatment to the observed ethnic differ-
ences in CVD. Finally, as in numerous studies, the clas-
sifications of the various ethnic groups were based on 
country of birth. Country of birth may reflect ethnicity 
reasonably well among some ethnic groups but is likely 
to be an unreliable proxy measure of ethnicity for other 
groups such as Surinamese.16 The results may be gener-
alised to other European settings with similar healthcare 
services and composition of ethnic groups.
COnClusIOn
The results of the current study suggest that the risk 
of CVD-related outcomes among patients with breast 
cancer vary by ethnicity. Surinamese and Turkey patients 
with breast cancer experienced a higher risk, whereas 
Indonesian patients had a slightly lower risk of CVD event 
compared with their Dutch counterparts. More exten-
sive cohort studies are needed to identify the forms of 
CVD that are most common in these groups as well as the 
potential factors contributing to these differences.
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